List of companies in Inserm Transfert Initiative's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Developer of FXR agonists for the treatment of severe kidney diseases. | ||||||
BIOMODEX develops and provides pre-operative training solutions for physicians based on 3D printing technology. | ||||||
The Hemarina technological platform is based on the peculiarities of the purified hemoglobin of lugworms, Arenicola marina . Its structure is comparable to that of human hemoglobin, however it is distinguished by: its extracellular character (it is not contained in a red blood cell), and therefore universal (compatibility with all blood groups) its ability to bind 40 times more oxygen than human hemoglobin its particularly small size: 250 times smaller than the human red blood cell | ||||||
Therachon is a company founded in 2014. | ||||||
Bioaxial is a Paris-based company founded in 2010. | ||||||
CellVir is a company founded in 2006. | ||||||
